Clinical Trial Update: Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in African-American and European-American Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating leflunomide for high-risk smoldering multiple myeloma in African-American and European-American patients; the study is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoldering Multiple Myeloma

Drugs mentioned

• Leflunomide (Leflunomide)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Smoldering Plasma Cell Myeloma | Phase 2 | Status: ACTIVE_NOT_RECRUITING